鼻窦手术与慢性鼻窦炎患者新发哮喘及非囊性纤维化支气管扩张的关联
本回顾性研究纳入2006至2013年一家学术中心的慢性鼻窦炎患者,比较接受与未接受内镜鼻窦手术者新发哮喘或非囊性纤维化支气管扩张的情况。中位随访至2023年,接受手术者新发哮喘风险较低(校正后OR 0.85,95%CI 0.73-0.99),支气管扩张风险无差异。
要点
- 内镜鼻窦手术与慢性鼻窦炎患者新发哮喘风险降低相关,校正后OR为0.85。
- 接受手术者鼻窦炎严重度更高(LM评分9.02 vs 4.28),但新发哮喘比例仍较低。
- 内镜鼻窦手术与新发非囊性纤维化支气管扩张无显著关联。
核心结论
- 尽管接受内镜鼻窦手术的慢性鼻窦炎患者疾病严重度更高,其新发哮喘诊断风险低于未手术者,且未增加新发非囊性纤维化支气管扩张风险。
研究设计与样本
- 接受内镜鼻窦手术者1877例,未接受手术者13453例;随机抽取部分患者计算Lund-Mackay评分评估疾病严重度。
- 采用Logistic回归估计内镜鼻窦手术状态与新发哮喘或支气管扩张的比值比。
主要发现
- 接受手术者中207/1877(11%)新发哮喘、40/1877(2.1%)新发支气管扩张;未手术者中1778/13453(13.2%)新发哮喘、293/13453(2.2%)新发支气管扩张。
- 未校正的新发哮喘比值比在手术组较未手术组低19%,OR(95%CI)为0.81(0.70-0.95)。
- 校正年龄、性别、种族/族裔、吸烟状态和慢性鼻炎后,手术组新发哮喘比值比降低15%,OR(95%CI)为0.85(0.73-0.99)。
- 内镜鼻窦手术状态与新发支气管扩张诊断无关联。
- 手术组Lund-Mackay评分为9.02,未手术组为4.28,提示手术组慢性鼻窦炎严重度更高。
关键数值与推荐
- 新发哮喘:手术组207/1877(11%),未手术组1778/13453(13.2%)。
- 新发支气管扩张:手术组40/1877(2.1%),未手术组293/13453(2.2%)。
- 未校正新发哮喘OR(95%CI)0.81(0.70-0.95);校正后OR(95%CI)0.85(0.73-0.99)。
- Lund-Mackay评分:手术组9.02,未手术组4.28。
临床怎么用
- 对慢性鼻窦炎患者评估内镜鼻窦手术时,可结合其对新发哮喘风险的潜在影响进行个体化决策。
- 术后随访中仍需关注下气道疾病,但本研究未显示手术增加支气管扩张风险。
局限性
- 为单中心回顾性研究,可能存在选择偏倚与混杂因素。
- 仅对随机子集计算Lund-Mackay评分,疾病严重度评估不完整。
- 随访时间及诊断依赖电子病历记录,可能存在漏诊或分类偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Precedent chronic rhinosinusitis (CRS) is associated with new-onset asthma and non-cystic fibrosis bronchiectasis (BE). OBJECTIVE: To assess if endoscopic sinus surgery (ESS) mitigates the development of lower airway diseases in patients with CRS. METHODS: This retrospective study utilized electronic medical records from an academic center. CRS patients (> 18 years old) without asthma or BE, were identified between January 2006 and December 2013. Charts were reviewed until May 2023. New diagnoses of asthma or BE were identified in patient records following ESS before December 2018 compared to patients without ESS. Lund-Mackay (LM) scores were calculated in a random subset of patients to assess disease severity. Logistic regression was used to estimate the odds of developing asthma or BE by ESS status. RESULTS: A total of 1877 patients underwent ESS, while 13,453 did not. CRS severity was higher in the ESS group (LM, 9.02) versus no ESS group (LM, 4.28). After up to 17 years of follow-up, 207/1877 (11%) and 40/1877 (2.1%) of patients with ESS had a new asthma or BE diagnosis, respectively. Out of 13,453 patients, 1778 (13.2%) and 293 (2.2%) patients without ESS had a new asthma or BE diagnosis. The unadjusted odds of a new asthma diagnosis were lower by 19% for ESS versus no ESS; OR (95% CI), 0.81 (0.70-0.95). After controlling for confounders (age, gender, race/ethnicity, smoking status, and chronic rhinitis), the association remained significant, with a 15% reduction in the odds of a new asthma diagnosis; OR (95% CI), 0.85 (0.73-0.99). There was no association between ESS status and a new diagnosis of BE. CONCLUSIONS: Despite higher CRS severity, patients undergoing ESS had a lower risk of a new asthma diagnosis and did not have a higher risk of developing BE.
引用
- Wautlet AJ, Vu TT, Chung E, et al. The Association Between Sinus Surgery and the Development of Asthma and Non-Cystic Fibrosis Bronchiectasis in Patients With Chronic Rhinosinusitis. Int Forum Allergy Rhinol. 2025. PMID: 41316714. doi:10.1002/alr.70074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。